Figure 2.

Agiogenesis after ADMSC transplantation. Immunohistochemical staining of factor VIII (FVIII) and microvessel counts. A, normal control. B, 18 weeks of CCl₄ administration. C, portal venous injection of irrelevant cells. D, portal vein ADMSC transplantation. E, tail vein ADMSC transplantation. F, microvessel counts. ADMSCs portal vein transplantation decreases VEGF expression in the fibrotic liver at gene and protein level. G, qPCR examination. H, Western blotting. *p < 0.05 versus 18 weeks of CCl₄ administration; #p < 0.05 between normal control and CCl₄ treatment (18w).